Results – Publications
Contents
Preliminary studies supporting the rationale of ICS-RECODE study
Preliminary studies supporting the rationale of the ICS-RECODE study
Post-hoc analysis of the ISOLDE trial, demonstrating that blood eosinophils measured while patients are receiving corticosteroids are not equivalent to blood eosinophils measured while patients are not receiving ICS. This study also established eosinophils change as a potential biomarker
- Mathioudakis AG, Bikov A, Foden P, Lahousse L, Brusselle G, Singh D, Vestbo J. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD. Eur Respir J. 2020;55(5):1902119. doi: 10.1183/13993003.02119-2019. Link to full text
Post-hoc analysis of the FLAME trial
Mathioudakis AG, Bate S, Sivapalan P, Jensen JU, Singh D, Vestbo J. Rethinking blood eosinophils for assessing ICS response in COPD: A post-hoc analysis from FLAME. In peer review.
Study Protocol
TBC
Main results
TBC
Methodological findings
TBC